These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7998725)

  • 41. Healthcare costs: Eden's apple?
    Johnston SC; Hauser SL
    Ann Neurol; 2012 Oct; 72(4):A4-5. PubMed ID: 23109164
    [No Abstract]   [Full Text] [Related]  

  • 42. NIH, science, and baseball: time for reform?
    Murphy EJ
    Lipids; 2010 Oct; 45(10):889-90. PubMed ID: 20859768
    [No Abstract]   [Full Text] [Related]  

  • 43. Health-related research.
    Acad Med; 1993 Sep; 68(9):725-8. PubMed ID: 8397644
    [No Abstract]   [Full Text] [Related]  

  • 44. Industry must communicate value and contribution of drugs to Congress and public.
    Gatty B
    Hosp Formul; 1994 May; 29(5):406, 405. PubMed ID: 10133903
    [No Abstract]   [Full Text] [Related]  

  • 45. Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study.
    Treasure CL; Avorn J; Kesselheim AS
    Milbank Q; 2015 Dec; 93(4):761-87. PubMed ID: 26626985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Academic medical centers fear squeeze from Affordable Care Act.
    Azvolinsky A
    Nat Med; 2014 Feb; 20(2):106. PubMed ID: 24504392
    [No Abstract]   [Full Text] [Related]  

  • 47. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
    Dorfman HL; Reig LP
    Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
    [No Abstract]   [Full Text] [Related]  

  • 48. Health care reform: implications for biomedical research.
    Rich RR
    FASEB J; 1994 Aug; 8(11):799. PubMed ID: 8070627
    [No Abstract]   [Full Text] [Related]  

  • 49. Priority initiatives in health care and research harmed by budget cuts.
    Kerschner JE
    WMJ; 2013 Jun; 112(3):141-2. PubMed ID: 23894813
    [No Abstract]   [Full Text] [Related]  

  • 50. NIH cost analysis of a contract proposal.
    Payne MD
    Grants Mag; 1984 Mar; 7(1):70-80. PubMed ID: 10270262
    [No Abstract]   [Full Text] [Related]  

  • 51. Grants4Targets: an open innovation initiative to foster drug discovery collaborations.
    Dorsch H; Jurock AE; Schoepe S; Lessl M; Asadullah K
    Nat Rev Drug Discov; 2015 Jan; 14(1):74-6. PubMed ID: 25430867
    [No Abstract]   [Full Text] [Related]  

  • 52. Funding health sciences research: a strategy to restore balance.
    Bloom FE; Bulger RE; Randolph MA
    Clin Res; 1990 Dec; 38(4):671-85. PubMed ID: 2177388
    [No Abstract]   [Full Text] [Related]  

  • 53. Federal requirements for performing cost analysis of a contract proposal.
    Powers RJ
    Grants Mag; 1984 Mar; 7(1):65-70. PubMed ID: 10270261
    [No Abstract]   [Full Text] [Related]  

  • 54. Academic medical centers: whence they came, where they went.
    Korn D
    J Soc Gynecol Investig; 1998; 5(5):227-36. PubMed ID: 9773397
    [No Abstract]   [Full Text] [Related]  

  • 55. Congress Passes 2006 NIH Reform Act.
    Lang L
    Gastroenterology; 2007 Feb; 132(2):474-5. PubMed ID: 17261310
    [No Abstract]   [Full Text] [Related]  

  • 56. Research funding. Health bill backs evidence-based medicine, new drug studies.
    Kaiser J
    Science; 2010 Mar; 327(5973):1562. PubMed ID: 20339036
    [No Abstract]   [Full Text] [Related]  

  • 57. Biotechnology transfer at the National Institutes of Health.
    Chen PS
    Qual Assur; 1993 Dec; 2(4):345-52. PubMed ID: 7952969
    [No Abstract]   [Full Text] [Related]  

  • 58. Biomedical research and technology development.
    Anderson GF; Russe GM
    Health Aff (Millwood); 1987; 6(2):85-92. PubMed ID: 3623411
    [No Abstract]   [Full Text] [Related]  

  • 59. NHLBI awards 68 million dollars to fund clinical centers in pediatric heart disease.
    J Investig Med; 2004 Apr; 52(3):165-6. PubMed ID: 15222405
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinton's breakthrough drug committee: will it stifle new drug development?
    Gatty B
    Hosp Formul; 1993 Nov; 28(11):946, 945. PubMed ID: 10130236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.